A clinical trial has dosed its first mesothelioma patient to examine the effectiveness of a new drug on attacking cancerous proteins. Curis, Inc., a biotechnology company...
Read Post
Pleural mesothelioma patients often face a high rate of recurrence after surgery. The goal of mesothelioma surgery is to accomplish complete macroscopic resection. However, most...
Read Post
According to the American Cancer Society’s annual Cancer Statistics Report, the overall mortality from cancer in the United States experienced a steady decline between 1991 and...
Read Post
Exercise scientist and Director of the Cardio-Oncology Research Program (CORP) at Memorial Sloan Kettering, Dr. Lee Jones, is attempting to figure out if prescribing...
Read Post
The New Year is a time of reflection and planning for the future. Taking stock of some personal goals in the coming year can help you remain focused and tackle any challenges that...
Read Post
Mesothelioma Expert Named President-elect of the American College of Surgeons
By: Alex Hall
November 29, 2018
In October, Dr. Valerie Rusch, MD, FACS, an attending thoracic surgeon at Memorial Sloan-Kettering Cancer Center, an ACS Fellow, and mesothelioma expert, was elected president of...
Read Post
November is National Caregiver Month and with Thanksgiving just around the corner, it is important to recognize all of the significant work that mesothelioma caregivers do for...
Read Post
Advances in imaging technology for early detection of mesothelioma as well as immunotherapy used in multimodal treatments have recently shown great promise to extend life...
Read Post
Dr. David Sugarbaker, a pioneer in the treatment of mesothelioma for over 30 years, suddenly passed away on August 29, 2018. He was a world-renowned thoracic surgeon and was a man...
Read Post
Over 20 years ago, researchers at the National Cancer Institute (NCI) discovered the antigen, mesothelin. To this day, it has been an attractive target for investigative studies...
Read Post